SANTA MONICA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that a letter to shareholders from CEO Matthew Schissler has been posted on the Company's website. The letter explains some of the positive scientific and economic implications of the potential enhanced stem cell research initiatives proposed by the new Obama Administration.
On Sunday, November 9, 2008, John Podesta, who is leading President Elect Barack Obama's transition team, told Fox News (http://www.foxnews.com/story/0,2933,449164,00.html):
"We're looking at -- again, in virtually every agency to see where we can move forward, whether that's on energy transformation, on improving health care, on stem cell research.
There's a lot that the president can do using his executive authority without waiting for congressional action, and I think we'll see the president do that ..."
Mr. Schissler commented, "Because of this interview, there seems to be a rejuvenated and heightened awareness to stem cells and the philosophy change that is anticipated from our President Elect. It is my hope that, through a series of communicative letters to shareholders and families alike, that CBAI can provide valuable information from both a macroeconomic perspective, as well as a direct relation to the individual."
"I am often asked the question: 'What does this mean for Cord Blood America?'" Mr. Schissler said. "Families ask us: 'What does this mean for my family, should I store stem cells, what are the differences between embryonic and adult stem cells, and what does the research mean to our medical community and our economy?'"
"We believe the letter that was posted today and which can be accessed at http://www.cordblood-america.com will help answer some of these questions," Cord Blood America's CEO said. "In summary, we believe that an infusion of capital into stem cell research and development will lead to more therapies being commercialized, a higher percentage of families benefiting from these therapies and, subsequently, a higher percentage of families choosing to store stem cells. We believe this is a significant positive for both stem cell companies and our shareholders."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at http://www.corcell.com. For investor information, visit http://www.cordblood-america.com.
Some statements made in this press release are forward-looking
statements, which are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. We use words such as
"anticipate," "believe," "expect," "future," "intend," "plan," and similar
expressions to identify forward-looking statements. These statements
including those related to the growth of the industry, new stem cell
treatments, and the Company's performance, are only predictions and are
subject to certain risks, uncertainties and assumptions. Additional risks
are identified and described in the Company's public filings with the
Securities and Exchange Commission. Statements made herein are as of the
date of this press release and should not be relied upon as of any
subsequent date. The Company's past performance is not necessarily
indicative of its future performance. The Company does not undertake, and
the Company specifically disclaims any obligation to update any
forward-looking statements to reflect occurrences, developments, events, or
circumstances after the date of such statement.
E & E Communications
|SOURCE Cord Blood America, Inc.|
Copyright©2008 PR Newswire.
All rights reserved